Artwork
iconShare
 
Manage episode 512612230 series 3643376
Content provided by Keith Parent. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Keith Parent or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this episode of the Driving the Business of Science podcast, hosted by Keith Parent, CEO of Court Square Group, guest Mark Connell, Co-Founder and President of SLBST Pharma, discusses the company’s mission to repurpose hydroxychloroquine to treat endometriosis, a condition affecting 7 million American women. Despite limited current therapies, SLBST Pharma aims to leverage the drug’s proven efficacy in reducing lesions by 60%. Challenges include navigating the complexities of drug development, fundraising, and staying agile amidst setbacks. Connell emphasizes the importance of tenacity, community engagement, and the ultimate goal of alleviating pain and improving lives.

  continue reading

18 episodes